2018 AANS Annual Scientific Meeting-Point/Counterpoint Session: Asymptomatic Carotid Disease

Point/Counterpoint Session: Asymptomatic Carotid Disease - Third Panelist

Video Transcription

Video Summary

The video transcript discusses the topic of treating patients with asymptomatic carotid artery disease. The speaker highlights previous landmark trials that suggest intervention can reduce stroke risk by 53% compared to medical management. However, the trials did not adequately compare medical management to intervention. The speaker also mentions newer trials that include a dedicated medical management arm and show favorable outcomes for medical treatment. The CREST2 trial aims to further evaluate medical management versus intervention for asymptomatic carotid stenosis. The speaker also discusses the importance of aggressive medical management, targetting risk factors, and the potential impact of revascularization on patient cognition. The transcript concludes with the speaker suggesting additional research opportunities for predicting which patients would benefit most from intervention. No credits were provided in the transcript.

Asset Caption

Gabriel Vidal, MD

Keywords

asymptomatic carotid artery disease

stroke risk reduction

medical management

intervention

CREST2 trial